日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Loa loa in the vitreous cavity of the eye

眼玻璃体腔内罗阿丝虫病

Nayak, Bhagabat; Sinha, Subijay; Nayak, Lipika

Managing bevacizumab-induced intraocular inflammation

控制贝伐单抗引起的眼内炎症

Sinha, Subijay; Vashisht, Nagender; Venkatesh, Pradeep; Garg, Sat Pal

Brilliant blue G-assisted peeling of the internal limiting membrane in macular hole surgery

黄斑裂孔手术中采用亮蓝G辅助剥离内界膜

Naithani, Prashant; Vashisht, Naginder; Khanduja, Sumeet; Sinha, Subijay; Garg, Satpal

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy

玻璃体内注射贝伐单抗治疗与贝斯特卵黄状营养不良相关的脉络膜新生血管

Mandal, Subrata; Sinha, Subijay; Venkatesh, Pradeep; Vashisht, Nagender

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy

玻璃体内注射贝伐单抗治疗活动性中心性浆液性脉络膜视网膜病变并发的黄斑下脉络膜新生血管

Mandal, Subrata; Sinha, Subijay; Abbas, Zahir; Venkatesh, Pradeep

Intravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian population

在印度人群中,玻璃体内注射贝伐单抗(阿瓦斯汀)治疗弥漫性糖尿病性黄斑水肿

Kumar, Atul; Sinha, Subijay